Search for the latest oncology news by tumour type
Drug used for breast and kidney cancers may also extend survival for head and neck cancers
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival…
Browsing: Tumour Stream
FDA approves neratinib for metastatic HER2-positive breast cancer
The Food and Drug Administration (FDA) approved neratinib in combination with capecitabine for adult patients…
Combined therapy may improve clinical responses for endometrial, colorectal and gastric tumours
A study at The University of Texas MD Anderson Cancer Center, USA, discovered a novel…
Genetic ‘fingerprints’ implicate gut bacterium in bowel cancer
A common type of bacteria found in our guts could contribute to bowel cancer, according…
A new strategy to prevent the most aggressive tumours from generating resistance to chemotherapy
One of the most frequent problems when treating cancer is that the tumours develop resistance…
Both BRCA1-wild type and mutant triple-negative breast cancers show
Oncotarget features “MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S…
Surveillance after surgery does not improve outcomes for patients with glioblastoma
Glioblastoma is an aggressive and deadly brain cancer. Although improved treatment protocols have doubled the…
Targeting stromal cells may help overcome treatment resistance in glioblastoma
The deadly brain cancer glioblastoma (GBM) is often resistant to chemotherapy and radiation, but new…
How cancer cells stiff-arm normal environmental cues to consume energy
Using human lung cancer cells, UT Southwestern, USA, researchers have uncovered how cells in general…
Immunotherapy combo effective for patients with high-grade neuroendocrine cancer
Many patients with rare, fast-growing neuroendocrine tumours respond well to a common immunotherapy drug combination,…